PharmaShots | Incisive News in 3 Shots

Subscribe Now

Rakuten Medical

Rakuten Medical Commences Global P-III (ECLIPSE) Study of ASP-1929 Plus Keytruda as a 1L Treatment of Recurrent Head and Neck Cancer

Rakuten Medical Commences Global P-III (ECLIPSE) Study of ASP-1929 Plus Keytruda as a 1L Treatment of Recurrent Head and Neck Canc...

January 27, 2025

Rakuten Medical Highlights the Preclinical Results of RM-0256 at JCA 2024

Rakuten Medical Highlights the Preclinical Results of RM-0256 at JCA 2024

September 20, 2024

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us